Company
Headquarters: Jakarta Timur, Indonesia
Employees: 2,392
CEO: Mr. Rogelio Castillo La O' Cooey Jr.
Rp8.821 Trillion
IDR as of July 1, 2024
US$538.7 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $622.07 B |
Vertex Pharmaceuticals Incorporated | $121.36 B |
Regeneron Pharmaceuticals, Inc. | $115.11 B |
CSL Limited | $95.75 B |
Marinomed Biotech AG | $75.67 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
PT Soho Global Health Tbk operates as a healthcare company in Indonesia. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and provides contract manufacturing services for various dosage forms, as well as distribution and logistics services. It also offers body defense, stamina and vitality, brain nutrient, eye health, skin care, weight management, and wellness products; sells and markets medical devices and medical equipment products in the areas of wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics; and provides product registration, marketing intelligence, sales, and marketing support services. The company was founded in 1946 and is based in Jakarta Timur, Indonesia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
PT Soho Global Health Tbk has the following listings and related stock indices.
Stock: IDX: SOHO wb_incandescent